| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Acute myeloid leukemia 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] RARA |
D02754 |
Acitretin |
[1] 37 |
| 2 | Adipocytokine signaling pathway 4 genes, 4 drugs (DrugBank), 28 diseases shown |
[3] RXRA, RXRB, RXRG |
D02754 |
Acitretin |
[1] 37 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 3 | African trypanosomiasis 3 genes, 4 drugs (DrugBank), 31 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 4 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 5 | Allograft rejection 3 genes, 4 drugs (DrugBank), 31 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 6 | Alzheimer disease 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 7 | Amoebiasis 5 genes, 5 drugs (DrugBank), 38 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 8 | Amyotrophic lateral sclerosis (ALS) 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 9 | Antifolate resistance 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 10 | Antigen processing and presentation 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 11 | Apoptosis 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 12 | Asthma 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 13 | Bile secretion 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] RXRA |
D02754 |
Acitretin |
[1] 37 |
| 14 | C-type lectin receptor signaling pathway 4 genes, 6 drugs (DrugBank), 31 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 15 | Cell adhesion molecules (CAMs) 2 genes, 2 drugs (DrugBank), 14 diseases shown |
[1] CD58 |
D02800 |
Alefacept |
[6] 37, 60, 65, 164, 284, 285 |
| [1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 16 | Chagas disease (American trypanosomiasis) 3 genes, 4 drugs (DrugBank), 31 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 17 | Cytokine-cytokine receptor interaction 8 genes, 10 drugs (DrugBank), 39 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL17A |
D10071 |
Ixekizumab |
[4] 37, 162, 269, 271 |
| D09967 |
Secukinumab |
[7] 13, 37, 41, 46, 160, 269, 271 |
| [1] IL17RA |
D10061 |
Brodalumab |
[2] 37, 51 |
| [2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 18 | Dilated cardiomyopathy (DCM) 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 19 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] VDR |
D00129 |
Calcitriol |
[8] 37, 46, 49, 66, 96, 158, 235, 326 |
| 20 | Epstein-Barr virus infection 3 genes, 5 drugs (DrugBank), 35 diseases shown |
[1] CD58 |
D02800 |
Alefacept |
[6] 37, 60, 65, 164, 284, 285 |
| [1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 21 | Estrogen signaling pathway 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] RARA |
D02754 |
Acitretin |
[1] 37 |
| 22 | Fc epsilon RI signaling pathway 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 23 | Fluid shear stress and atherosclerosis 3 genes, 4 drugs (DrugBank), 36 diseases shown |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 24 | Gastric cancer 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] RARB, RXRA, RXRB, RXRG |
D02754 |
Acitretin |
[1] 37 |
| 25 | Graft-versus-host disease 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 26 | Hematopoietic cell lineage 3 genes, 4 drugs (DrugBank), 36 diseases shown |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 27 | Hepatitis B 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 28 | Hepatitis C 2 genes, 4 drugs (DrugBank), 28 diseases shown |
[1] RXRA |
D02754 |
Acitretin |
[1] 37 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 29 | Herpes simplex virus 1 infection 3 genes, 4 drugs (DrugBank), 31 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 30 | Human cytomegalovirus infection 2 genes, 4 drugs (DrugBank), 36 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 31 | Human immunodeficiency virus 1 infection 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 32 | Human papillomavirus infection 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 33 | Human T-cell leukemia virus 1 infection 4 genes, 5 drugs (DrugBank), 39 diseases shown |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 34 | Hypertrophic cardiomyopathy (HCM) 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 35 | IL-17 signaling pathway 3 genes, 6 drugs (DrugBank), 30 diseases shown |
[1] IL17A |
D10071 |
Ixekizumab |
[4] 37, 162, 269, 271 |
| D09967 |
Secukinumab |
[7] 13, 37, 41, 46, 160, 269, 271 |
| [1] IL17RA |
D10061 |
Brodalumab |
[2] 37, 51 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 36 | Inflammatory bowel disease (IBD) 5 genes, 8 drugs (DrugBank), 31 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL17A |
D10071 |
Ixekizumab |
[4] 37, 162, 269, 271 |
| D09967 |
Secukinumab |
[7] 13, 37, 41, 46, 160, 269, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 37 | Inflammatory mediator regulation of TRP channels 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 38 | Influenza A 3 genes, 4 drugs (DrugBank), 31 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 39 | Insulin resistance 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 40 | JAK-STAT signaling pathway 3 genes, 3 drugs (DrugBank), 16 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| 41 | Legionellosis 3 genes, 4 drugs (DrugBank), 31 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 42 | Leishmaniasis 3 genes, 4 drugs (DrugBank), 31 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 43 | Leukocyte transendothelial migration 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 44 | Malaria 3 genes, 5 drugs (DrugBank), 33 diseases shown |
[1] IL12A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 45 | MAPK signaling pathway 2 genes, 4 drugs (DrugBank), 36 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 46 | Measles 2 genes, 1 drug (DrugBank), 16 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 47 | Mineral absorption 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] VDR |
D00129 |
Calcitriol |
[8] 37, 46, 49, 66, 96, 158, 235, 326 |
| 48 | mTOR signaling pathway 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 49 | Natural killer cell mediated cytotoxicity 2 genes, 4 drugs (DrugBank), 32 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 50 | Necroptosis 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 51 | NF-kappa B signaling pathway 2 genes, 4 drugs (DrugBank), 36 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 52 | NOD-like receptor signaling pathway 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 53 | Non-alcoholic fatty liver disease (NAFLD) 2 genes, 4 drugs (DrugBank), 28 diseases shown |
[1] RXRA |
D02754 |
Acitretin |
[1] 37 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 54 | Non-small cell lung cancer 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] RARB, RXRA, RXRB, RXRG |
D02754 |
Acitretin |
[1] 37 |
| 55 | Osteoclast differentiation 2 genes, 4 drugs (DrugBank), 36 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 56 | Parathyroid hormone synthesis, secretion and action 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[3] RXRA, RXRB, RXRG |
D02754 |
Acitretin |
[1] 37 |
| [1] VDR |
D00129 |
Calcitriol |
[8] 37, 46, 49, 66, 96, 158, 235, 326 |
| 57 | Pathogenic Escherichia coli infection 2 genes, 4 drugs (DrugBank), 36 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 58 | Pathways in cancer 8 genes, 4 drugs (DrugBank), 16 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| [5] RARA, RARB, RXRA, RXRB, RXRG |
D02754 |
Acitretin |
[1] 37 |
| 59 | Pertussis 4 genes, 6 drugs (DrugBank), 31 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 60 | PI3K-Akt signaling pathway 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] RXRA |
D02754 |
Acitretin |
[1] 37 |
| 61 | PPAR signaling pathway 3 genes, 1 drug (DrugBank), 1 disease shown |
[3] RXRA, RXRB, RXRG |
D02754 |
Acitretin |
[1] 37 |
| 62 | Prostate cancer 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 63 | Proteoglycans in cancer 2 genes, 4 drugs (DrugBank), 31 diseases shown |
[1] IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 64 | Rap1 signaling pathway 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 65 | Regulation of actin cytoskeleton 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 66 | Rheumatoid arthritis 4 genes, 9 drugs (DrugBank), 33 diseases shown |
[1] IL17A |
D10071 |
Ixekizumab |
[4] 37, 162, 269, 271 |
| D09967 |
Secukinumab |
[7] 13, 37, 41, 46, 160, 269, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 67 | RIG-I-like receptor signaling pathway 3 genes, 4 drugs (DrugBank), 31 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 68 | Shigellosis 2 genes, 4 drugs (DrugBank), 36 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 69 | Small cell lung cancer 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] RARB, RXRA, RXRB, RXRG |
D02754 |
Acitretin |
[1] 37 |
| 70 | Sphingolipid signaling pathway 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 71 | Staphylococcus aureus infection 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 72 | Systemic lupus erythematosus 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 73 | T cell receptor signaling pathway 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 74 | TGF-beta signaling pathway 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 75 | Th1 and Th2 cell differentiation 2 genes, 1 drug (DrugBank), 16 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 76 | Th17 cell differentiation 7 genes, 7 drugs (DrugBank), 25 diseases shown |
[1] IL17A |
D10071 |
Ixekizumab |
[4] 37, 162, 269, 271 |
| D09967 |
Secukinumab |
[7] 13, 37, 41, 46, 160, 269, 271 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [4] RARA, RXRA, RXRB, RXRG |
D02754 |
Acitretin |
[1] 37 |
| 77 | Thyroid cancer 3 genes, 1 drug (DrugBank), 1 disease shown |
[3] RXRA, RXRB, RXRG |
D02754 |
Acitretin |
[1] 37 |
| 78 | Thyroid hormone signaling pathway 3 genes, 1 drug (DrugBank), 1 disease shown |
[3] RXRA, RXRB, RXRG |
D02754 |
Acitretin |
[1] 37 |
| 79 | TNF signaling pathway 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 80 | Toll-like receptor signaling pathway 3 genes, 4 drugs (DrugBank), 31 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 81 | Toxoplasmosis 3 genes, 4 drugs (DrugBank), 31 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 82 | Transcriptional misregulation in cancer 5 genes, 2 drugs (DrugBank), 17 diseases shown |
[1] IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [4] RARA, RXRA, RXRB, RXRG |
D02754 |
Acitretin |
[1] 37 |
| 83 | Tuberculosis 5 genes, 7 drugs (DrugBank), 35 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| [1] VDR |
D00129 |
Calcitriol |
[8] 37, 46, 49, 66, 96, 158, 235, 326 |
| 84 | Type I diabetes mellitus 3 genes, 4 drugs (DrugBank), 31 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 85 | Type II diabetes mellitus 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 86 | Viral myocarditis 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 87 | Viral protein interaction with cytokine and cytokine receptor 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 88 | Yersinia infection 1 gene, 3 drugs (DrugBank), 28 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |